Our intellectual property
Protecting Innovation,
Driving Advantage
At Promethea Biochem Solutions, intellectual property is the bridge between research and market deployment, central to how we transform R&D into competitive advantage. Our IP strategy safeguards discoveries while creating opportunities for licensing, partnerships, and secure freedom to operate for our partners.
Our IP portfolio includes:
- Proprietary DES systems for extraction, solubilization, and stabilization.
- Patented encapsulation and controlled release technologies.
- Innovative formulations and production processes.
- Exclusive licensing agreements with academia and industry.
- Data packages, technical dossiers, and regulatory authorizations.
A collaborative IP model:
- License in technologies from academia, industry and startups to enrich our pipeline.
- Out-license proprietary solutions to accelerate partner adoption.
- Build shared IP frameworks that maximize mutual value creation.
Soon, this section will feature our active patent families, proprietary formulations, and technology platforms. Until then, discover how our pipeline is shaping tomorrow’s IP-protected biochemical innovations.
